APAC to see highest growth in the global single-cell analysis market

Thanks to a focus on cell-based therapies and high government investment.

The Asia-Pacific (APAC) region is expected to witness the highest growth in the global single-cell analysis market, which is projected to reach $7.56m by 2030, according to MarketsandMarkets.

The region’s expansion is attributed to a rising focus on cell-based therapies, substantial government investment in research and development, and a ‘booming’ healthcare sector.

Moreover, modernising healthcare infrastructure and adopting advanced technologies for research and clinical use are expected to drive market growth in the APAC.

Meanwhile, the global market is driven by a rise in cancer and immunological disorders, technological developments, and an increasing focus on stem cell research and the biotechnology sector.